Introduction: Hip fracture is the most severe consequence of osteoporosis and an important cause of excess mortality in the elderly. Objective: We aimed to evaluate the in-hospital mortality rate after osteoporotic hip fracture in patients treated surgically or functionally in specialized centers in Bucharest. Materials and methods: We calculated the in-hospital mortality rate in 745 patients (540 women [72.48%], with a mean age of 79.1 ± 11 years), surgically or functionally treated for fragility hip fracture over a 12 months period. Results: Average length of hospitalization was 18.12 days. In hospital mortality rate was 5.36% (n=40, women 60%). An important risk factor associated with mortality was age, p=0.001. The male sex was also a risk factor with a mortality rate of 7,8% (n=16), compared to 4.44% in women, p<0.005, with OR of 1.57. Out of the 40 patients, 57.5% had a femoral neck fracture, 35% intertrochanteric, and 5.5% atypical fracture in absence of bisphosphonates. 7.5% had previous fragility fractures. 85% of the patients had a history of one or more cardiac pathologies (34.28% with atrial fibrillation), 57.5% underwent surgical intervention (n=23) with an average day of intervention of 8.82 after admission. None of the patients had an osteoporosis treatment before the event and on average 3.73 medications with an increased risk of falling and fracture. Conclusion: In-hospital mortality rate after hip fracture remains high; probably this being related to the high comorbidity associated with male sex and increased age as risk factors.
Introduction
Osteoporosis is a disorder characterized by low bone mass and microarchitectural disruption that results in bone fragility and risk of fractures with minimal trauma (less or equal that a fall from a standing position). Elderly population is the fastest growing population worldwide and the incidence of fragility fracture is expected to rise substantially but even if it remained stable it is estimated to rise from 1.7 million in 1990 to 6.3 in 2050 [1] . Annually, in Romania, it is estimated that almost 100.000 fragility fractures occur, 15 .000 being located on the hip and being sustained, thus making our country a moderate risk country for the hip fracture [2] .
Hip fracture remains the most important clinical manifestation of osteoporosis, with a high and relatively unchanged mortality rate in the last decades [3] . In-hospital mortality is an important statistical measure, being used in some countries as a reliable quality indicator of healthcare.
To our knowledge, there are not any studies regarding the mortality rate after hip fracture in Romania [4] .
In this study, we aimed to evaluate the in-hospital mortality rate after osteoporotic hip fracture in patients treated surgically or functionally in specialized centers in Bucharest, to compare it to the data existing in literature and to look for associated predictive factors of increased mortality risk.
Patients and methods
We calculated the in-hospital mortality rate after hip fracture in 745 patients (540 women [72.48%], with a mean age of 79.1 ± 11 years) admitted in 3 trauma centers in Bucharest, from 01.09.2017 to 31.08.2018.
Patients with the home addresses in Bucharest were 52.5% and 66.71% from urban areas. We selected retrospectively all the patients with S72.0x, S72.1x and S72.2x, S72.3x (femoral neck, intertrochanteric, subtrochanteric, subtrochanteric-diaphyseal coded as only diaphyseal) from the electronic databases of the selected centers. All charts were reviewed for data validation. The rest of the data (address, medical history, treatment, day of admission after fracture, type of surgery, day of the intervention, and diagnoses) was also collected from the patient's charts (physical and electronic in 86.5% and only electronic chart in 13.5%).
We excluded patients younger than 40 years old, high intensity trauma fractures, and pathological fractures, even when suspicion existed with no further investigations.
For data analysis, Microsoft Excel 16.16.8, 2016 was used.
Results
In-hospital mortality rate was 5.36% (n=40, women 60%).
An important risk factor associated with mortality was age, p=0.001.
The male sex was also a risk factor with a mortality rate of 7,8% (n=16), compared to 4.44% in women, p<0.005, with OR of 1.57.
Out of the 40 patients, 57.5% had a femoral neck fracture, 35% intertrochanteric, and 5.5% atypical fracture in the absence of bisphosphonates, percentages that were slightly different in the whole population studied, with a mortality rate of 6.4% for the femoral neck fracture compared to 4.9% for the other types, with OR of 1.3.
57.5% sustained surgical interventions (n=23) with a mortality rate of 3.6% in surgically treated patients compared to 16% in the functionally treated group. The average day of intervention of 8.82 after admission compared to 3.61 in the patients who survived, made the postponing of the surgical intervention a risk factor, p=0.007. The average length of hospitalization was 18.12 days compared to 11.68 days per patient in the survival group.
85% of the patients had a history of one or more cardiac pathologies (34.28% with atrial fibrillation) compared to 82.12% in the other group. Also, when talking about respiratory disorders, the prevalence was 7.5% compared to 9.2% in the survival group. History of prevalent fracture was present in 17.26% of the patients included with 56.25% located also at the hip level. 10% of the patients who died had a prevalent fracture, with 50% located at the hip level.
Discussions
The in-hospital mortality rate in our study was 5.36%, consistent with the reported rates [14] .
Although most of the studies regarding osteoporotic hip fracture include only femoral neck and intertrochanteric fracture, the number of subtrochanteric ones was very small and we preferred to include them.
Regarding the average day of the intervention, we could observe that patients who died during hospital admission were operated later than the survival group. 20% of the patients who died during hospitalization had anemia compared to 7.9% in the survival group and the proportion of patients on anticoagulation therapy in the patients that did not survive was 27.5% compared to 1.27% patients discharged. The optimum timing of surgery for a hip fracture is an important topic for researchers but still with no clear consensus. It is generally accepted that early surgery is beneficial [15, 16] , the more fitted patients can benefit from it but the frail patients need a delay for correction of eventual surgical risk factors like anemia, anticoagulation or electrolyte imbalance [17] .
It is very hard to state if functionally treated fractures are at an increased risk of mortality, these patients already presenting a high presurgical mortality risk that contraindicated the surgery. Only one patient refused the surgery and 3 of them had an extremely severe state.
It is necessary to expand the study to observe the impact of functionally treated fractures versus surgically treated ones on the 30 days and 12 months mortality rate.
We need further studies to expand the evaluation of the mortality rate to 30 days and even 12 months after the hip fracture. It is important to assess how much of the inhospital mortality rate contributes to the 30 days mortality rate.
The data raised questions about the relationship between the surgical timing delay and the mortality rate. We need further studies to see what the causes of surgical timing delay in our hospitals are, to differentiate from other problems like availability of resources, and intervene if possible.
Further studies are necessary to separately assess the subtrochanteric, diaphyseal and distal femur, and to search for common characteristics and to compare the mortality rate and the risk factors of mortality with the age-related osteoporosis hip fractures [18] . The limitations of the study reside in the lack of uniformity in our data collecting systems and the ICD-10 codes. Unfortunately, regarding comorbidities data and treatment history, this type of study has many limitations and depends on the medical staff that is responsible for the patient chart. A prospective study is indicated.
Conclusions
Mortality rate after hip fracture remains high but relatively similar to the one in literature data. We managed to validate some of the mortality risk factors present in published literature.
